Bruce N. Jacobs sold $8.9M of Kymera Therapeutics (KYMR)

Executed Jun 30, disclosed Jul 2, 2 days later.

Value, as filed

$8.9M

77,109 sh across 8 lots

Executed

Jun 30

the trade date, as filed

Disclosed

Jul 2

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Bruce N. Jacobs Chief Financial Officer profile →

Bruce N. Jacobs (Chief Financial Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Kymera Therapeutics, Inc. (KYMR). The largest single filing was $8.9M of KYMR (77,109 sh across 8 lots, as filed), executed Jun 30.

The name

KYMR

Kymera Therapeutics, Inc. KYMR · Healthcare · 58 filings in 24 months ticker →

Healthcare · Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics th…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Bruce N. Jacobs in KYMR

KYMRSALE Kymera Therapeutics, Inc. $1.0M
11,532 sh across 5 lots
Exec Mar 2
Filed Mar 4 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. $4.0M
79,220 sh × $50.00
Exec Sep 17 2025
Filed Sep 17 2025 · 5:30 PM ET KYMRSALE Kymera Therapeutics, Inc. $175K
5,754 sh × $30.33
Exec Mar 3 2025
Filed Mar 3 2025 · 5:30 PM ET